Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Treasury Shares (2016 - 2025)

Catalyst Pharmaceuticals (CPRX) has disclosed Treasury Shares for 6 consecutive years, with $1.0 million as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Treasury Shares rose 145.29% year-over-year to $1.0 million, compared with a TTM value of $1.0 million through Dec 2022, up 145.29%, and an annual FY2022 reading of $1.0 million, up 145.29% over the prior year.
  • Treasury Shares was $1.0 million for Q4 2022 at Catalyst Pharmaceuticals, up from -$600000.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.0 million in Q4 2022 and bottomed at -$2.2 million in Q4 2021.
  • Average Treasury Shares over 4 years is $14463.4, with a median of $235671.0 recorded in 2020.
  • The sharpest move saw Treasury Shares plummeted 1036.9% in 2021, then surged 145.29% in 2022.
  • Year by year, Treasury Shares stood at $352500.0 in 2019, then crashed by 33.14% to $235671.0 in 2020, then tumbled by 1036.9% to -$2.2 million in 2021, then soared by 145.29% to $1.0 million in 2022.
  • Business Quant data shows Treasury Shares for CPRX at $1.0 million in Q4 2022, -$600000.0 in Q2 2022, and -$400000.0 in Q1 2022.